Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
Go back to Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner| Danaher Corp. (NYSE: DHR) | Delayed: 211.81 -0.69 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $212.50 | 52 Week High | $102.79 | |||
| Open | $212.64 | 52 Week Low | $75.71 | |||
| Day High | $214.98 | P/E | 55.74 | |||
| Day Low | $210.10 | EPS | $3.80 | |||
| Volume | 8,835,005 | |||||
